When hemoglobin and hematocrit are high, the first move is to investigate the underlying cause. This guidance covers the diagnostic steps—detailed history, focused physical, labs like erythropoietin levels, and when a bone marrow biopsy may be needed—emphasizing why addressing the root issue matters.

Multiple Choice

During a routine examination, a 55-year-old female has elevated hemoglobin and hematocrit levels. What should be the next step in her evaluation?

The next step in the evaluation of a patient with elevated hemoglobin and hematocrit levels is to conduct further investigation into the cause of the elevation. This approach is essential because elevated levels can indicate various underlying conditions, such as polycythemia vera, chronic hypoxia, or dehydration, and each of these conditions requires a different management strategy. Investigating the cause will typically include a detailed patient history, physical examination, and specialized laboratory tests, such as erythropoietin levels or even a bone marrow biopsy, depending on the clinical context. Understanding the source of the elevation is crucial for determining the appropriate treatment and management plan, as simply treating the symptom without addressing the underlying issue could lead to complications. Immediate blood transfusions and referrals to a hematologist might become necessary later, depending on the findings from the investigation, but they are not the first step in this evaluation. Reinforcing hydration practices might be relevant if dehydration is suspected to be the cause of the elevated levels; however, assuming that without further information would be premature. Hence, prioritizing further investigations aligns with a thorough and careful diagnostic approach in clinical practice.

When numbers climb, the question isn’t always obvious. A routine check showing elevated hemoglobin (Hb) and hematocrit (Hct) can set off alarms in a clinician’s mind, but it’s a clue, not a conclusion. In practice, the first move is a careful, methodical search for the cause. Why? Because high Hb and Hct can whisper about a range of conditions—from simply concentrated blood due to dehydration to more complex disorders like polycythemia vera or chronic hypoxia. Jumping to a quick fix without understanding the root would be like turning up the heat in a house that’s not properly insulated.

Let me explain the logic behind the next steps and how clinicians navigate this terrain with a calm, curious approach.

Start with a thoughtful history and a precise physical exam

The journey begins at the bedside. A focused history helps separate the possible culprits. Ask about:

  • Respiratory symptoms or high-altitude exposure: Has the patient recently lived at altitude, traveled to high elevations, or has a chronic lung condition? Do they snore or have sleep-disordered breathing?

  • Smoking status: Tobacco use can raise Hb and Hct by increasing carbon monoxide exposure, which lowers oxygen delivery and triggers red cell production.

  • Hydration and recent fluid shifts: A transient rise can occur with dehydration or diuretic use.

  • Cardiovascular and renal history: Chronic heart failure or kidney disease can influence erythropoietin production.

  • Medications and supplements: Androgens, erythropoietin-stimulating agents, and certain supplements can affect red cell mass.

  • Symptoms suggesting polycythemia or hypoxia: headaches, dizziness, ruddy complexion, chest pain, or easy bruising may hint at different pathways.

A physical exam follows the history. Look for signs of dehydration (dry skin, mucous membranes), cyanosis or clubbing, signs of chronic lung disease, or splenomegaly, which could point toward hematologic or structural clues. The aim is to categorize the elevation: is it a relative rise from hemoconcentration, or an absolute increase in red cell mass? That distinction guides the gears that turn next.

Confirm the basics and then expand the workup

Some steps are almost routine, but they matter. A repeat Hb and Hct with a fresh sample controls for lab variability. Ensure there’s no ongoing dehydration, recent blood transfusion, or fluid shifts. If the values remain elevated, a practical framework helps: determine whether the body is producing more red cells (absolute polycythemia) or if the blood has simply become concentrated (relative polycythemia).

Key tests that commonly follow include:

  • Oxygenation assessment: Pulse oximetry or arterial blood gas analysis to see how well oxygen is getting to tissues. Chronic hypoxia is a common driver of secondary polycythemia.

  • Erythropoietin (EPO) level: This hormone is the signal that tells the bone marrow to make more red cells. Inappropriate EPO elevation can point to secondary causes (like chronic hypoxia from lung disease), while low EPO with a high Hb/Hct raises concerns for a primary marrow disorder.

  • Carboxyhemoglobin and iron studies: If smoking or recent exposure to carbon monoxide is suspected, these help quantify the impact. Iron status matters too; iron deficiency can coexist with high Hb/Hct and complicate the picture.

  • Renal and liver function tests: The kidneys and liver play roles in erythropoietin production and iron metabolism, so evaluating their function helps triangulate the cause.

  • Chest imaging and sleep studies: If chronic hypoxia looms large, imaging can reveal lung disease, and sleep studies can uncover obstructive sleep apnea, both of which can drive secondary polycythemia.

  • Hematologic-specific tests: If the story points toward a primary hematologic process, tests such as JAK2 V617F mutation analysis, other myeloproliferative neoplasm markers, and, in certain contexts, a bone marrow biopsy may be warranted.

The “why” behind the tests is just as important as the tests themselves

Understanding the rationale keeps the process humane and practical. If elevated Hb/Hct is due to dehydration, the fix is straightforward: restore fluid balance and recheck. But if the elevation stems from a marrow-driven disorder like polycythemia vera, the approach shifts dramatically—from simple hydration tweaks to targeted therapies and long-term monitoring. If secondary polycythemia arises from chronic lung disease, the plan centers on optimizing oxygen delivery and managing the underlying condition. Each pathway has its own language, its own set of priorities, and its own potential complications.

When to bring in specialists and how to manage the moment

This isn’t a situation where you press a single button and move on. In many cases, the workup unfolds with a primary care team coordinating tests and interpreting results. Depending on the clues that emerge, referrals may be appropriate:

  • Hematology: Considered when ruling in or out myeloproliferative neoplasms or when marrow evaluation is needed.

  • Pulmonology or cardiology: If chronic hypoxia or cardiovascular disease seems to be the driver, specialists can fine-tune treatment and surveillance.

  • Sleep medicine: If sleep-disordered breathing is suspected, a sleep study can reveal the missing piece.

But here’s the thing: even when a referral feels like the natural next step, the initial evaluation remains about causation, not just management. The patient deserves a coherent narrative—one that connects symptoms, test results, and the practical steps that follow.

What about dehydrate-and-reassess scenarios? They happen, and they’re real

It’s tempting to think: “If they’re dehydrated, fix fluids and we’re done.” Not so fast. Dehydration can masquerade as a red cell surplus, but the question remains: what caused the dehydration in the first place? Is it a simple heat exposure, diuretic overuse, or something more subtle like an underlying illness or medication effect? Reassessing Hb/Hct after rehydration helps ensure the elevation truly reflects red cell mass rather than a momentary state. It’s a small step, but it keeps the picture honest.

Common missteps to avoid

  • Jumping to a single pivot: Treating dry, high Hb/Hct with a presumptive therapy without exploring causes risks mismanaging the root problem.

  • Overlooking coexistent iron deficiency: It can camouflage or complicate the interpretation of red cell parameters.

  • Delaying a thorough assessment for too long: The longer you wait to investigate, the more you risk missing a treatable underlying condition.

Real-world analogies that help the concept click

Think of Hb and Hct as a ship’s cargo manifest. If the cargo suddenly appears heavy, you don’t immediately unload the crates. You first ask: Is the ship lighter crew due to who’s aboard? Did we lose water ballast? Are there storms around that elevate overall oxygen demand? Each question narrows the field and points to the right intervention.

Or picture it like tuning a guitar. The string—blood—puts out a pitch. If the pitch is high, you don’t just tighten the string; you check the tuning pegs, the neck, and even the air around the instrument. Sometimes the issue is in the instrument (a hematologic condition), sometimes it’s in the air (hypoxia or dehydration), and sometimes it’s in the player’s technique (lifestyle factors). The melody depends on finding the right source.

A practical, holistic takeaway for clinicians and students

Elevated Hb and Hct aren’t a red flag that screams “do this now.” They’re a diagnostic invitation. The smart move is to map out potential causes, run targeted tests, and let the patient’s unique story guide the next steps. This approach cultivates a measured, thoughtful practice that respects both the science and the person in front of you.

As you move through clinical scenarios like this, keep a few anchors in mind:

  • Start with the patient’s story and a careful exam. Clear context makes all the difference.

  • Verify whether the elevation reflects absolute red cell mass or relative concentration.

  • Use a tiered testing strategy: basics first (oxygenation, EPO, iron, renal/liver function), then more specialized tests if needed (JAK2, bone marrow evaluation).

  • Tailor the plan to the discovered cause. Treat the root, not just the symptom.

  • Don’t rush to a reflex solution. Patience and precision pay off in patient outcomes.

If you’re studying pathophysiology, pharmacology, and physical assessment, this scenario is a nice microcosm of a bigger truth: clinical thinking blends science with storytelling. You’re not just collecting data; you’re weaving a narrative that explains why the body is behaving a certain way and what can be done to restore balance.

A closing thought

Elevated Hb and Hct are signals, not verdicts. They invite inquiry, collaboration, and careful reasoning. The next step isn’t a shortcut; it’s a thoughtful, structured chase after the underlying cause. And while the path may branch—dehydration, secondary polycythemia from hypoxia, or a primary hematologic condition—the compass remains the same: understand, investigate, and adapt the plan to what best helps the patient regain stability and well‑being.